Pages that link to "Q45238896"

The following pages link to Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma. (Q45238896):

Displaying 24 items.

• Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinoma (Q21261248) (← links)
• The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivo (Q26827175) (← links)
• Recent developments in targeting carbonic anhydrase IX for cancer therapeutics (Q27013023) (← links)
• Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients (Q30318094) (← links)
• The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study (Q33610032) (← links)
• Tumor microenvironmental changes induced by the sulfamate carbonic anhydrase IX inhibitor S4 in a laryngeal tumor model (Q34205104) (← links)
• αB-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinoma (Q34626414) (← links)
• Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study. (Q35078927) (← links)
• Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors (Q35103263) (← links)
• High-uptake areas on positron emission tomography with the hypoxic radiotracer (18)F-FRP170 in glioblastomas include regions retaining proliferative activity under hypoxia (Q36322855) (← links)
• Linking hypoxia, DNA damage and proliferation in multicellular tumor spheroids (Q36375935) (← links)
• The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma (Q37214341) (← links)
• Molecular aspects of tumour hypoxia (Q37453827) (← links)
• Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers (Q37690276) (← links)
• Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors (Q37710994) (← links)
• Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers (Q38132855) (← links)
• Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases (Q38154554) (← links)
• Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response (Q38871848) (← links)
• Hypoxia in head and neck squamous cell carcinoma (Q41480144) (← links)
• Carbonic anhydrase-9 expression in head and neck cancer: a meta-analysis (Q44624222) (← links)
• Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX. (Q47097799) (← links)
• Impact of tumoral carbonic anhydrase IX and Ki-67 expression on survival in oral squamous cell carcinoma patients (Q47227510) (← links)
• Tumor Hypoxia Imaging (Q53272680) (← links)
• Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers. (Q55442510) (← links)